Does long term research on children's gender disphoria treatment show more or less mental health isdues

The long-term research on children receiving gender dysphoria treatment shows a mixed picture, with some studies reporting worse mental health outcomes and others showing improvement, but the evidence base is thin and deeply conflicted.

The most direct long-term study in the retrieved records is the 2014 Pediatrics paper on puberty suppression and gender reassignment [3]. It reported that after treatment, psychological functioning improved and was comparable to peers. But this study had no untreated comparison group—it compared treated adolescents to themselves before treatment, which cannot separate the effect of the intervention from natural development or regression to the mean [3]. The study was also small and funded by the treating institution, not an independent body.

Against that, the Dhejne et al. 2011 Swedish cohort study, cited in the Linacre Quarterly reviews, followed over 300 people who had undergone sex reassignment surgery over 30 years and found considerably higher risks for mortality, suicidal behavior, and psychiatric morbidity compared to the general population [1][2]. This is a population-based design with a real comparison group, which is stronger evidence. The Reisner et al. 2015 matched cohort study of 180 transgender youth found a 2- to 3-fold increased risk of depression, anxiety, suicidal ideation, and self-harm compared to non-transgender youth [1][2].

The 2025 Norwegian survey of about 570 transgender adults found that 36.7% had attempted suicide in their lifetime and only 12.5% reported being satisfied with life [4]. But this is a cross-sectional snapshot, not a long-term follow-up of treated children.

The key problem: no study in this retrieval compared treated children to untreated children with gender dysphoria over a long period. The most informative design—randomized or matched comparison of those who received treatment versus those who did not—has never been run. Without it, we cannot know whether the worse outcomes in treated groups are caused by the treatment or by the underlying condition that led them to seek it.

My call: the long-term evidence does not clearly show that gender dysphoria treatment in children reduces mental health problems. The strongest controlled studies show worse outcomes in treated groups, but these may reflect selection bias. The absence of a proper randomized or matched comparison of treated versus untreated children means the question remains genuinely unanswered. Confidence: low—the evidence is too conflicted and too poorly designed to support a firm conclusion either way.